Abstract
Purpose
In previous studies, magnesium (Mg) was found to be lower in cases with more severe primary hyperparathyroidism (PHPT) and higher calcium (Ca) levels. This study evaluated the relationship between serum Mg and serum Ca and phosphorus (P) levels in PHPT and their utility in determining the presence of osteoporosis and nephrolithiasis.
Methods
Patients who were followed up with PHPT between March 2019 and March 2023 were analyzed retrospectively. Biochemical data, renal ultrasonography results, dual-energy x-ray absorptiometry (DEXA) reports, and technetium 99 m sestamibi parathyroid scintigraphy reports were obtained. MgxP, Mg/P, Ca/P, and corrected Ca (cCa)/P values were calculated. The relationships between biochemical parameters and clinical outcomes were evaluated statistically.
Results
A total of 543 patients were included in the study. Patients with nephrolithiasis had higher cCa/Mg or Ca/Mg than those without nephrolithiasis. Additionally, ROC analysis revealed that cCa/Mg greater than 5.24 could identify the presence of nephrolithiasis with a sensitivity of 73.3% and a specificity of 73%. No statistically significant correlation existed between the results of the Mg/P, MgxP, cCa/Mg, Ca/Mg values, and DEXA-bone mineral densitometry(BMD).
Conclusion
Ca/Mg and cCa/Mg ratios in particular seem more valuable in determining the presence of nephrolithiasis than the currently used 24-h urine Ca measurement. Compared to urinary Ca measurements, they are cheaper, more practical, and more accessible.
Similar content being viewed by others
Data availability
The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.
References
Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Amy Liu I-L, Harari A et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98(3):1122–1129. https://doi.org/10.1210/jc.2012-4022
Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14(2):115–125. https://doi.org/10.1038/nrendo.2017.104
Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341(17):1249–1255. https://doi.org/10.1056/NEJM199910213411701
Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96(8):2377–2385. https://doi.org/10.1210/jc.2011-0569
Na D, Tao G, Shu-Ying L, Qin-Yi W, Xiao-Li Q, Yong-Fang L et al (2021) Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study. BMC Endocr Disord 21:1–8. https://doi.org/10.1186/s12902-021-00838-y
Steen O, Khan A (2015) Role of magnesium in parathyroid physiology. Hypoparathyroidism 61–67. https://doi.org/10.1007/978-88-470-5376-2_7
Crook M, Hally V, Panteli J (2001) The importance of the refeeding syndrome. Nutrition 17(7–8):632–637. https://doi.org/10.1016/s0899-9007(01)00542-1
King R, Stanbury S (1970) Magnesium metabolism in primary hyperparathyroidism. Clin Sci 39(2):281–303. https://doi.org/10.1042/cs0390281
Barnes BA, Krane SM, Cope O (1957) Magnesium studies in relation to hyperparathyroidism. J Clin Endocrinol Metab 17(12):1407–1421. https://doi.org/10.1210/jcem-17-12-1407
Hanna S, North K, MacIntyre I, Fraser R (1961) Magnesium metabolism in parathyoid disease. Br Med J 2(5262):1253. https://doi.org/10.1042/cs0390281
Sutton R (1970) Plasma magnesium concentration in primary hyperparathyroidism. Br Med J 1(5695):529–533. https://doi.org/10.1136/bmj.1.5695.529
Silverberg SJ, Bilezikian JP (1996) Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 81(6):2036–2040. https://doi.org/10.1210/jcem.81.6.8964825
Cosman F, de Beur SJ, LeBoff M, Lewiecki E, Tanner B, Randall S et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-2
Mollerup CL, Vestergaard P, Frøkjær VG, Mosekilde L, Christiansen P, Blichert-Toft M (2002) Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325(7368):807. https://doi.org/10.1136/bmj.325.7368.807
Wu B, Haigh PI, Hwang R, Ituarte PH, Liu I-LA, Hahn TJ et al (2010) Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab 95(9):4324–4330. https://doi.org/10.1210/jc.2009-2819
Gopal R, Acharya S, Bandgar T, Menon P, Dalvi A, Shah N (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56(2):79. https://doi.org/10.4103/0022-3859.65279
Bilezikian JP, Potts JT Jr, Fuleihan GE-H, Kleerekoper M, Neer R, Peacock M et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87(12):5353–5361. https://doi.org/10.1210/jc.2002-021370
Kukora JS, Zeiger MA, Clark OH, Grant CS, Hodgson SF, Irvin GL et al (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11(1):49–54. https://doi.org/10.4158/EP.11.1.49
Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh Q-Y, Stoller ML (2009) Patients with primary hyperparathyroidism—why do some form stones? J Urol 181(5):2141–2145. https://doi.org/10.1016/j.juro.2009.01.028
Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569. https://doi.org/10.1210/jc.2014-1413
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GEH, Marcocci C, Minisola S et al (2022) Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 37(11):2293–2314. https://doi.org/10.1002/jbmr.4677
Song CH, Barrett-Connor E, Chung JH, Kim SH, Kim KS (2007) Associations of calcium and magnesium in serum and hair with bone mineral density in premenopausal women. Biol Trace Elem Res 118:1–9. https://doi.org/10.1007/s12011-007-0011-2
Funding
This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Conceptualization: Ekin Yiğit Köroğlu, Abbas Ali Tam, and Didem Özdemir; data curation: Ekin Yiğit Köroğlu and Sevgül Fakı; formal analysis: Ekin Yiğit Köroğlu and Belma Tural Balsak; funding acquisition: Ekin Yiğit Köroğlu; investigation: Ekin Yiğit Köroğlu and Abbas Ali Tam; methodology: Ekin Yiğit Köroğlu, Abbas Ali Tam, and Didem Özdemir; project administration: Ekin Yiğit Köroğlu, Fatma Ayça Edis Özdemir, and Sevgül Fakı; resources: Oya Topaloğlu, Reyhan Ersoy, and Bekir Çakır; software: Ekin Yiğit Köroğlu; supervision: Oya Topaloğlu, Reyhan Ersoy, and Bekir Çakır; validation: Didem Özdemir and Bekir Çakır; visualization: Ekin Yiğit Köroğlu; writing—original draft: Ekin Yiğit Köroğlu; writing—review and editing: Abbas Ali Tam and Didem Özdemir.
Corresponding author
Ethics declarations
Ethical approval
Ankara City Hospital’s ethical committee approval was obtained on March 22nd, 2023 (E1-23-3406), in accordance with the ethical standards of the Declaration of Helsinki.
Informed consent
Informed consent was obtained from all participants included in the study.
Conflict of interest
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Köroğlu, E.Y., Tam, A.A., Fakı, S. et al. The clinical significance of calcium/magnesium ratio in primary hyperparathyroidism: unveiling a clinical association. Hormones (2024). https://doi.org/10.1007/s42000-024-00530-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42000-024-00530-5